Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus (the only FDA-approved semaglutide products, manufactured by Novo Nordisk)
Lifestyle Habits GLP-1 medications cannot replace healthy routines
The type of obesity that responds best for this medication is exogenous obesity, which refers to the condition wherein an individual consumes food that is more than the required level of activity, which in turn results in increased fat storage
If you experience severe side effects and that do not subside with time, stop taking semaglutide and consult your doctor
The 10mg lyophilized vial is formulated for subcutaneous injection
Underlying health conditions like uncontrolled diabetes, thyroid dysfunction, or metabolic syndrome can blunt semaglutide's effects regardless of proper administration